Abstract
Background: In patients with gallbladder cancer, jaundice suggests tumor involvement of the porta hepatis. This study reports on the prevalence, etiology, and clinical significance of jaundice in patients with gallbladder cancer.
Methods: Patients who presented with gallbladder cancer from 1995 to 2002 were entered into a prospective database. Disease-specific survival and clinicopathologic correlates were analyzed.
Results: Eighty-two (34%) of 240 patients with gallbladder cancer presented with jaundice. Jaundiced patients (96%) were more likely (P < .001) to have advanced-stage disease than nonjaundiced patients (60%). Only six (7%) jaundiced patients were resected with curative intent, and only four (5%) had negative surgical margins. This was significantly different from the nonjaundiced group, in which 62 patients (39%) had negative margins (P < .001). The median disease-specific survival in patients presenting with jaundice was 6 months and was significantly lower compared with 16 months in patients without jaundice (P < .0001). In the group presenting with jaundice, there were no disease-free survivors at 2 years, compared with 21% in the group without jaundice.
Conclusions: Jaundice is common (34%) in patients who present with gallbladder cancer and is an indicator of advanced malignancy. These data do not support routine operative exploration of patients with jaundice secondary to gallbladder cancer.
Similar content being viewed by others
References
Piehler JM, Crichlow RW. Primary carcinoma of gallbladder. Surg Gynecol Obstet 1978;147:929–42.
Pack GT, Miller TR, Brasfield RD. Total right hepatic resection lobectomy for cancer of the gallbladder. Ann Surg 1955;142:6–16.
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000;232:557–66.
Wagholikar GD, Behari A, Krishnani N, et al. Early gallbladder cancer. J Am Coll Surg 2002;194:137–41.
Ouchi K, Owada Y, Matsuno S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery 1987;101:731–7.
Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 1994;219:275–80.
Wilkinson DS. Carcinoma of the gallbladder—an experience and review of the literature. Aust N Z J Surg 1995;65:724–7.
Ogura Y, Mizumoto R, Isaji S, Kusuda T, Matsuda S, Tabata M. Radical operations for carcinoma of the gallbladder—present status in Japan. World J Surg 1991;15:337–43.
Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA. Carcinoma of the gallbladder—does radical resection improve outcome? Arch Surg 1990;125:237–41.
Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Extensive surgery for carcinoma of the gallbladder. Br J Surg 2002;89:179–84.
Blalock A. A statistical study of 888 cases of biliary tract disease. Johns Hopkins Hosp Bull 1924;35:391–409.
De Aretxabala XA, Roa IS, Burgos LA, Araya JC, Villaseca MA, Silva JA. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 1997;163:419–26.
Matsumoto Y, Fujii H, Aoyama H, Yamamoto M, Sugahara K, Suda K. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 1992;163:239–45.
Shirai Y, Yoshida K, Tsukada K, Muto T, Watanabe H. Radical surgery for gallbladder carcinoma—long-term results. Ann Surg 1992;216:565–8.
Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder—an appraisal of a radical 2nd operation after simple cholecystectomy. Ann Surg 1992;215:326–31.
Onoyama H, Yamamoto M, Tseng A, Ajiki T, Saitoh Y. Extended cholecystectomy for carcinoma of the gallbladder. World J Surg 1995;19:758–63.
Oertli D, Herzog U, Tondelli P. Primary carcinoma of the gallbladder—operative experience during a 16 year period. Eur J Surg 1993;159:415–20.
Bartlett DL, Fong YM, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer—implications for staging and management. Ann Surg 1996;224:639–46.
Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery 1989;106:467–73.
Weber SM, DeMatteo RP, Fong YM, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma—analysis of 100 patients. Ann Surg 2002;235:392–9.
Schwartz LH, Gruen DR, Winston CB, Jamagin WR, Fong Y, Panicek DM. MR imaging and MR cholangiopancreatography of gallbladder cancer. Radiology 1998;209P:485.
Schwartz LH, Black J, Fong Y, et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography. J Comput Assist Tomogr 2002;26:405–10.
Thorbjarnarson B. Carcinoma of biliary tree. 1. Carcinoma of gallbladder. N Y State J Med 1975;75:550–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hawkins, W.G., DeMatteo, R.P., Jarnagin, W.R. et al. Jaundice Predicts Advanced Disease and Early Mortality in Patients With Gallbladder Cancer. Ann Surg Oncol 11, 310–315 (2004). https://doi.org/10.1245/ASO.2004.03.011
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2004.03.011